<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Acquired Hemolytic | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Acquired [Immune-Mediated] Hemolytic Anemias  Definition: Hemolysis (RBC destruction) that occurs due to the binding of antibodies and/or complement proteins to the surface of RBCs...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Acquired Hemolytic | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Acquired [Immune-Mediated] Hemolytic Anemias  Definition: Hemolysis (RBC destruction) that occurs due to the binding of antibodies and/or complement proteins to the surface of RBCs...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Acquired Hemolytic | Hematology">
<meta name="twitter:description" content="Overview of Acquired [Immune-Mediated] Hemolytic Anemias  Definition: Hemolysis (RBC destruction) that occurs due to the binding of antibodies and/or complement proteins to the surface of RBCs...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="active" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="acquired-hemolytic" class="section level1 unnumbered">
<h1>Acquired Hemolytic<a class="anchor" aria-label="anchor" href="#acquired-hemolytic"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-acquired-immune-mediated-hemolytic-anemias" class="section level2 unnumbered">
<h2>
<strong>Overview of Acquired [Immune-Mediated] Hemolytic Anemias</strong><a class="anchor" aria-label="anchor" href="#overview-of-acquired-immune-mediated-hemolytic-anemias"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> Hemolysis (RBC destruction) that occurs due to the binding of antibodies and/or complement proteins to the surface of RBCs</li>
<li>
<strong>Hallmark:</strong> A positive Direct Antiglobulin Test (DAT), also known as a Coombs test. The DAT detects the presence of antibodies or complement proteins bound to RBCs</li>
<li>
<strong>Classification:</strong>
<ul>
<li>
<strong>Autoimmune Hemolytic Anemia (AIHA):</strong> Antibodies are directed against the individual’s own RBC antigens
<ul>
<li>Warm AIHA</li>
<li>Cold AIHA (Cold Agglutinin Disease)</li>
<li>Paroxysmal Cold Hemoglobinuria (PCH)</li>
</ul>
</li>
<li>
<strong>Drug-Induced Hemolytic Anemia:</strong> Antibodies are produced as a result of drug exposure</li>
<li>
<strong>Alloimmune Hemolytic Anemia:</strong> Antibodies are directed against foreign RBC antigens, typically following transfusion or during pregnancy
<ul>
<li>Hemolytic Disease of the Fetus and Newborn (HDFN)</li>
<li>Hemolytic Transfusion Reactions</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="mechanisms-of-immune-mediated-hemolysis" class="section level2 unnumbered">
<h2>
<strong>Mechanisms of Immune-Mediated Hemolysis</strong><a class="anchor" aria-label="anchor" href="#mechanisms-of-immune-mediated-hemolysis"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>The Players</strong>
<ul>
<li>
<strong>Red Blood Cells (RBCs):</strong> Our innocent bystanders in this scenario, carrying antigens on their surface that can be mistakenly targeted by the immune system</li>
<li>
<strong>Antibodies:</strong> Immunoglobulins (IgG or IgM) produced by B lymphocytes that can bind to specific antigens on the RBC surface</li>
<li>
<strong>Complement System:</strong> A group of plasma proteins that, when activated, can lead to cell lysis, inflammation, and enhanced phagocytosis</li>
<li>
<strong>Mononuclear Phagocyte System (MPS) / Reticuloendothelial System (RES):</strong> A network of phagocytic cells (macrophages) located throughout the body (especially in the spleen and liver) that engulf and destroy antibody- and/or complement-coated RBCs</li>
</ul>
</li>
<li>
<strong>The Process</strong>
<ol style="list-style-type: decimal">
<li>
<strong>Sensitization (Antibody Binding):</strong>
<ul>
<li>The process begins when antibodies bind to antigens on the surface of RBCs. These antigens can be:
<ul>
<li>
<strong>Self-antigens:</strong> In autoimmune hemolytic anemia (AIHA), the antibodies are autoantibodies that mistakenly recognize the individual’s own RBC antigens as foreign</li>
<li>
<strong>Drug-related antigens:</strong> In drug-induced hemolytic anemia, the antibodies may be directed against a drug that has adsorbed to the RBC surface or against a drug-antibody complex</li>
<li>
<strong>Foreign antigens:</strong> In alloimmune hemolytic anemia, the antibodies are alloantibodies that recognize foreign RBC antigens from a previous transfusion or from the fetus during pregnancy</li>
</ul>
</li>
<li>The type of antibody involved (IgG or IgM) and the density of antigen sites on the RBC influence the subsequent steps</li>
</ul>
</li>
<li>
<strong>Activation of the Complement System (Complement-Mediated Hemolysis):</strong>
<ul>
<li>This is more common with IgM antibodies, but IgG can also activate complement</li>
<li>The classical pathway of complement activation is triggered when C1q binds to the Fc region of IgM or IgG antibodies on the RBC surface</li>
<li>This leads to a cascade of events, resulting in the sequential activation of other complement proteins (C1, C4, C2, C3, C5, C6, C7, C8, and C9)</li>
<li>Key Steps:
<ul>
<li>
<strong>C3 Convertase Formation:</strong> C4b2a (C3 convertase) cleaves C3 into C3a and C3b</li>
<li>
<strong>C5 Convertase Formation:</strong> C4b2a3b (C5 convertase) cleaves C5 into C5a and C5b</li>
<li>
<strong>Membrane Attack Complex (MAC) Assembly:</strong> C5b initiates the assembly of the MAC (C5b-C6-C7-C8-C9) on the RBC membrane</li>
</ul>
</li>
<li>Outcomes of Complement Activation:
<ul>
<li>
<strong>Intravascular Hemolysis:</strong> The MAC inserts into the RBC membrane, creating pores that disrupt the cell’s osmotic balance, leading to lysis (rupture) within the blood vessels</li>
<li>
<strong>Opsonization:</strong> C3b opsonizes (coats) RBCs, making them more recognizable to phagocytes in the MPS (see below)</li>
<li>
<strong>Anaphylatoxins:</strong> C3a and C5a are released and act as anaphylatoxins, promoting inflammation and attracting immune cells</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Extravascular Hemolysis (MPS-Mediated):</strong>
<ul>
<li>Even if the complement cascade isn’t fully activated to the point of forming the MAC, antibody- and/or complement-coated RBCs are targeted for destruction by the MPS, primarily in the spleen and liver</li>
<li>The Process:
<ul>
<li>
<strong>Opsonization:</strong> RBCs are coated with IgG antibodies and/or complement fragments (primarily C3b)</li>
<li>
<strong>Recognition by Macrophages:</strong> Macrophages in the spleen and liver express:
<ul>
<li>Fc receptors that bind to the Fc region of IgG antibodies</li>
<li>Complement receptors (e.g., CR1) that bind to C3b</li>
</ul>
</li>
<li>
<strong>Phagocytosis:</strong> Macrophages engulf and destroy the antibody- and/or complement-coated RBCs</li>
</ul>
</li>
<li>Consequences of Phagocytosis:
<ul>
<li>
<strong>RBC Destruction:</strong> The RBC is broken down within the macrophage</li>
<li>
<strong>Hemoglobin Breakdown:</strong> Hemoglobin is metabolized into:
<ul>
<li>Globin: Broken down into amino acids</li>
<li>Iron: Recycled or stored as ferritin/hemosiderin</li>
<li>Porphyrin: Converted to bilirubin, which is released into the circulation</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ol>
</li>
<li>
<strong>Key Players in More Detail</strong>
<ul>
<li>
<strong>Antibodies (IgG and IgM):</strong>
<ul>
<li>
<strong>IgG:</strong>
<ul>
<li>More efficient at opsonization and promoting extravascular hemolysis</li>
<li>Can cross the placenta and cause HDFN</li>
<li>Warm AIHA is typically IgG-mediated</li>
</ul>
</li>
<li>
<strong>IgM:</strong>
<ul>
<li>More efficient at activating the complement cascade, leading to intravascular hemolysis</li>
<li>Cannot cross the placenta (due to its large size)</li>
<li>Cold AIHA is typically IgM-mediated</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Complement System:</strong>
<ul>
<li>A cascade of plasma proteins that, when activated, can lead to:
<ul>
<li>Cell lysis (formation of the MAC)</li>
<li>Opsonization (coating cells to enhance phagocytosis)</li>
<li>Inflammation (release of anaphylatoxins)</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Mononuclear Phagocyte System (MPS) / Reticuloendothelial System (RES):</strong>
<ul>
<li>A network of phagocytic cells (primarily macrophages) that remove debris and participate in immune responses</li>
<li>In immune-mediated hemolysis, the MPS is responsible for:
<ul>
<li>Recognizing and engulfing antibody- and/or complement-coated RBCs</li>
<li>Breaking down the RBCs and recycling their components</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="types-of-immune-mediated-hemolytic-anemias" class="section level2 unnumbered">
<h2>
<strong>Types of Immune-Mediated Hemolytic Anemias</strong><a class="anchor" aria-label="anchor" href="#types-of-immune-mediated-hemolytic-anemias"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Autoimmune Hemolytic Anemia (AIHA)</strong>
<ul>
<li>
<strong>Definition:</strong> Anemia caused by autoantibodies directed against the individual’s own RBC antigens</li>
<li>
<strong>Warm Autoimmune Hemolytic Anemia (Warm AIHA):</strong>
<ul>
<li>Antibody Type: IgG</li>
<li>Temperature Reactivity: Reacts optimally at body temperature (37°C)</li>
<li>Mechanism:
<ul>
<li>IgG antibodies bind to RBCs</li>
<li>RBCs are opsonized and phagocytized by macrophages in the spleen (extravascular hemolysis)</li>
<li>Some complement activation may occur</li>
</ul>
</li>
<li>Etiology:
<ul>
<li>Primary (idiopathic): No underlying cause</li>
<li>Secondary: Associated with autoimmune disorders (e.g., SLE), lymphoproliferative disorders (e.g., CLL), infections, or drugs</li>
</ul>
</li>
<li>Laboratory Findings:
<ul>
<li>DAT: Positive for IgG (and sometimes complement)</li>
<li>Peripheral Blood Smear: Spherocytes, polychromasia</li>
<li>Increased reticulocyte count</li>
<li>Elevated bilirubin and LDH</li>
<li>Decreased haptoglobin</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Cold Autoimmune Hemolytic Anemia (Cold AIHA):</strong>
<ul>
<li>Antibody Type: IgM.</li>
<li>Temperature Reactivity: Reacts optimally at low temperatures (4°C)</li>
<li>Mechanism:
<ul>
<li>IgM antibodies bind to RBCs in colder parts of the body (e.g., extremities)</li>
<li>This activates the complement cascade, leading to:
<ul>
<li>Intravascular hemolysis (formation of MAC)</li>
<li>Opsonization of RBCs with C3b, leading to splenic sequestration (extravascular hemolysis)</li>
</ul>
</li>
<li>IgM antibodies may detach from RBCs at warmer temperatures, but complement fragments remain bound, leading to RBC destruction</li>
</ul>
</li>
<li>Etiology:
<ul>
<li>Acute Cold AIHA (Cold Agglutinin Disease): Often associated with infections (e.g., <em>Mycoplasma pneumoniae</em>, infectious mononucleosis). The IgM antibodies are often transient and disappear after the infection resolves</li>
<li>Chronic Cold AIHA: Associated with lymphoproliferative disorders (e.g., Waldenström macroglobulinemia)</li>
</ul>
</li>
<li>Laboratory Findings:
<ul>
<li>DAT: Positive for complement (C3d) only. IgG is usually negative because IgM detaches from RBCs</li>
<li>Peripheral Blood Smear: RBC agglutination (clumping of RBCs)</li>
<li>Increased reticulocyte count</li>
<li>Elevated bilirubin and LDH</li>
<li>Decreased haptoglobin</li>
<li>Cold Agglutinin Titer: Elevated (measures the concentration of cold-reacting IgM antibodies)</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Paroxysmal Cold Hemoglobinuria (PCH):</strong>
<ul>
<li>Antibody Type: IgG antibody called the Donath-Landsteiner antibody</li>
<li>Temperature Reactivity: Binds to RBCs at low temperatures and causes complement-mediated hemolysis upon warming</li>
<li>Mechanism:
<ul>
<li>The Donath-Landsteiner antibody binds to the P antigen on RBCs at low temperatures</li>
<li>Upon warming to body temperature, the antibody activates the complement cascade, leading to intravascular hemolysis</li>
</ul>
</li>
<li>Etiology:
<ul>
<li>Historically associated with syphilis</li>
<li>Now more commonly associated with viral infections in children</li>
</ul>
</li>
<li>Clinical Features:
<ul>
<li>Sudden onset of hemolytic anemia, often after exposure to cold</li>
<li>Hemoglobinuria (dark urine)</li>
<li>Fever, chills, abdominal pain</li>
</ul>
</li>
<li>Laboratory Findings:
<ul>
<li>CBC: Anemia</li>
<li>Peripheral Blood Smear: May show spherocytes, polychromasia</li>
<li>Reticulocyte Count: Elevated</li>
<li>Elevated bilirubin and LDH</li>
<li>Decreased haptoglobin</li>
<li>DAT: Positive for complement (C3d) only</li>
<li>Donath-Landsteiner Test: Positive (confirms the presence of the Donath-Landsteiner antibody)</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Drug-Induced Hemolytic Anemia</strong>
<ul>
<li>
<strong>Mechanism:</strong>
<ul>
<li>Drug Adsorption: Drug binds to the RBC membrane, and antibodies are directed against the drug-RBC complex</li>
<li>Immune Complex Formation: Drug binds to antibody in the plasma, and the immune complex binds to RBCs, leading to complement activation</li>
<li>Autoantibody Formation: Drug induces the production of autoantibodies against RBCs (similar to warm AIHA)</li>
</ul>
</li>
<li>
<strong>Common Drugs:</strong>
<ul>
<li>Penicillin and cephalosporins (drug adsorption)</li>
<li>Quinidine and quinine (immune complex formation)</li>
<li>Methyldopa (autoantibody formation)</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC: Anemia</li>
<li>Peripheral Blood Smear: Spherocytes, polychromasia</li>
<li>Reticulocyte Count: Elevated</li>
<li>DAT: Positive (may be positive for IgG, complement, or both)</li>
<li>Drug-specific antibody testing (may be available)</li>
</ul>
</li>
<li>
<strong>Treatment:</strong> Discontinue the offending drug</li>
</ul>
</li>
<li>
<strong>Alloimmune Hemolytic Anemia</strong>
<ul>
<li>
<strong>Hemolytic Disease of the Fetus and Newborn (HDFN):</strong>
<ul>
<li>Mechanism:
<ul>
<li>Maternal alloantibodies (usually IgG) cross the placenta and attack fetal RBCs</li>
<li>Most commonly caused by Rh incompatibility (anti-D) or ABO incompatibility</li>
<li>Rh Incompatibility: Rh-negative mother is exposed to Rh-positive fetal blood during pregnancy or delivery, leading to the production of anti-D antibodies. In subsequent pregnancies, these antibodies cross the placenta and attack Rh-positive fetal RBCs</li>
<li>ABO Incompatibility: Mother with blood type O has anti-A and anti-B IgG antibodies that can cross the placenta and attack fetal RBCs (usually milder than Rh incompatibility)</li>
</ul>
</li>
<li>Clinical Features:
<ul>
<li>Fetal anemia, hydrops fetalis (severe edema), jaundice after birth</li>
</ul>
</li>
<li>Laboratory Findings:
<ul>
<li>Maternal Antibody Screening: Detects the presence of alloantibodies in the mother’s serum</li>
<li>DAT on Newborn RBCs: Positive for IgG (and sometimes complement)</li>
<li>Bilirubin: Elevated in the newborn</li>
</ul>
</li>
<li>Prevention:
<ul>
<li>RhoGAM (Rh immune globulin) is administered to Rh-negative mothers during pregnancy and after delivery to prevent Rh sensitization</li>
</ul>
</li>
<li>Treatment:
<ul>
<li>Intrauterine transfusions for severe fetal anemia</li>
<li>Exchange transfusions after birth to reduce bilirubin levels</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Hemolytic Transfusion Reactions:</strong>
<ul>
<li>Mechanism:
<ul>
<li>Recipient produces alloantibodies against donor RBC antigens (e.g., anti-A, anti-B, anti-Rh antibodies)</li>
<li>Transfused RBCs are attacked by recipient antibodies, leading to hemolysis</li>
</ul>
</li>
<li>Types:
<ul>
<li>Acute Hemolytic Transfusion Reaction: Occurs within minutes to hours after transfusion. Symptoms include fever, chills, chest pain, back pain, and hemoglobinuria</li>
<li>Delayed Hemolytic Transfusion Reaction: Occurs days to weeks after transfusion. Symptoms may be milder</li>
</ul>
</li>
<li>Laboratory Findings:
<ul>
<li>DAT: Positive on post-transfusion RBCs</li>
<li>Antibody Identification: Detects alloantibodies in the patient’s serum</li>
<li>Elevated bilirubin and LDH</li>
<li>Decreased haptoglobin</li>
</ul>
</li>
<li>Treatment:
<ul>
<li>Stop the transfusion immediately</li>
<li>Supportive care (IV fluids, vasopressors)</li>
<li>Manage complications (e.g., acute renal failure, DIC)</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="general-laboratory-findings-in-immune-mediated-hemolytic-anemias" class="section level2 unnumbered">
<h2>
<strong>General Laboratory Findings in Immune-Mediated Hemolytic Anemias</strong><a class="anchor" aria-label="anchor" href="#general-laboratory-findings-in-immune-mediated-hemolytic-anemias"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Complete Blood Count (CBC):</strong>
<ul>
<li>Anemia (low HGB and HCT)</li>
<li>MCV: May be normocytic or macrocytic (due to reticulocytosis)</li>
</ul>
</li>
<li>
<strong>Peripheral Blood Smear:</strong>
<ul>
<li>Spherocytes</li>
<li>Polychromasia</li>
<li>RBC agglutination (in cold AIHA)</li>
</ul>
</li>
<li>
<strong>Reticulocyte Count:</strong>
<ul>
<li>Elevated</li>
</ul>
</li>
<li>
<strong>Bilirubin:</strong>
<ul>
<li>Elevated unconjugated (indirect) bilirubin</li>
</ul>
</li>
<li>
<strong>Lactate Dehydrogenase (LDH):</strong>
<ul>
<li>Elevated</li>
</ul>
</li>
<li>
<strong>Haptoglobin:</strong>
<ul>
<li>Decreased or absent</li>
</ul>
</li>
<li>
<strong>Direct Antiglobulin Test (DAT):</strong>
<ul>
<li>Positive:
<ul>
<li>Warm AIHA: Positive for IgG (and sometimes complement)</li>
<li>Cold AIHA: Positive for complement (C3d) only</li>
<li>Drug-Induced Hemolytic Anemia: May be positive for IgG, complement, or both</li>
<li>HDFN: Positive for IgG</li>
<li>Hemolytic Transfusion Reactions: Positive for IgG, complement, or both</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-11" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-11"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Autoimmune Hemolytic Anemia (AIHA):</strong> Anemia caused by autoantibodies against RBCs</li>
<li>
<strong>Warm AIHA:</strong> IgG-mediated hemolysis at body temperature</li>
<li>
<strong>Cold AIHA:</strong> IgM-mediated hemolysis at low temperatures</li>
<li>
<strong>Paroxysmal Cold Hemoglobinuria (PCH):</strong> IgG-mediated hemolysis triggered by cold exposure</li>
<li>
<strong>Drug-Induced Hemolytic Anemia:</strong> Hemolysis caused by drug-induced antibodies</li>
<li>
<strong>Alloimmune Hemolytic Anemia:</strong> Hemolysis due to alloantibodies against foreign RBC antigens</li>
<li>
<strong>Hemolytic Disease of the Fetus and Newborn (HDFN):</strong> Maternal antibodies attack fetal RBCs</li>
<li>
<strong>Direct Antiglobulin Test (DAT):</strong> Test to detect antibodies or complement on RBCs</li>
<li>
<strong>Spherocytes:</strong> Spherical red blood cells</li>
<li>
<strong>Polychromasia:</strong> Increased number of reticulocytes</li>
<li>
<strong>Cold Agglutinins:</strong> IgM antibodies that cause RBC agglutination at low temperatures</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="hereditary-hemolytic.html">Hereditary Hemolytic</a></div>
<div class="next"><a href="hypoproliferative.html">Hypoproliferative</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#acquired-hemolytic">Acquired Hemolytic</a></li>
<li><a class="nav-link" href="#overview-of-acquired-immune-mediated-hemolytic-anemias">Overview of Acquired [Immune-Mediated] Hemolytic Anemias</a></li>
<li><a class="nav-link" href="#mechanisms-of-immune-mediated-hemolysis">Mechanisms of Immune-Mediated Hemolysis</a></li>
<li><a class="nav-link" href="#types-of-immune-mediated-hemolytic-anemias">Types of Immune-Mediated Hemolytic Anemias</a></li>
<li><a class="nav-link" href="#general-laboratory-findings-in-immune-mediated-hemolytic-anemias">General Laboratory Findings in Immune-Mediated Hemolytic Anemias</a></li>
<li><a class="nav-link" href="#key-terms-11">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/blob/main/book/01-04-09-erythrocyte-normocytic-acquired-hemolytic.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/blob/edit/main/book/01-04-09-erythrocyte-normocytic-acquired-hemolytic.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-28 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
